Event Presentation: CEO Ozawa Spoke at the 50th Animal Cell Technology Symposium
On May 12, 2025, Epistra CEO Yosuke Ozawa presented at the “FY2023 JAACT Technology Award & Encouragement Award Ceremony and 50th Animal Cell Technology Symposium: AI x Bioproduction,” held at the Nihonbashi Life Science Building.
Theme: “Autonomous Optimization of Life Science Experiments Using AI”
The presentation, titled “AI-powered Optimization of Experimental Protocols — From Pharmaceuticals to Biomaterials,” discussed the advancement of research and development spanning pharmaceutical development to biomaterial manufacturing.
AI Discussion in the Panel Session
In the panel discussion following the presentation, panelists engaged in discussion with particular focus on topics such as “black-box optimization,” “precautions when using generative AI,” and “hallucinations (errors generated by AI).” The session drew many questions from the audience, demonstrating strong interest in AI applications.
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.